Table of Contents Author Guidelines Submit a Manuscript
The Scientific World Journal
Volume 2016, Article ID 6507692, 11 pages
http://dx.doi.org/10.1155/2016/6507692
Research Article

Reduced Appendicular Lean Body Mass, Muscle Strength, and Size of Type II Muscle Fibers in Patients with Spondyloarthritis versus Healthy Controls: A Cross-Sectional Study

1Diakonhjemmet Hospital, National Unit for Rehabilitation in Rheumatology, Department of Rheumatology, Postboks 23 Vinderen, 0319 Oslo, Norway
2Norwegian School of Sport Sciences, Sognsveien 220, 0863 Oslo, Norway
3Diakonhjemmet Hospital, National Advisory Unit on Rehabilitation in Rheumatology, Postboks 23 Vinderen, 0319 Oslo, Norway

Received 18 April 2016; Revised 17 July 2016; Accepted 9 August 2016

Academic Editor: Lars Holm

Copyright © 2016 Kristine Røren Nordén et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Dougados and D. Baeten, “Spondyloarthritis,” The Lancet, vol. 377, no. 9783, pp. 2127–2137, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. S. Mathieu, B. Pereira, and M. Soubrier, “Cardiovascular events in ankylosing spondylitis: an updated meta-analysis,” Seminars in Arthritis and Rheumatism, vol. 44, no. 5, pp. 551–555, 2015. View at Publisher · View at Google Scholar · View at Scopus
  3. C. Ambarus, N. Yeremenko, P. P. Tak, and D. Baeten, “Pathogenesis of spondyloarthritis: autoimmune or autoinflammatory?” Current Opinion in Rheumatology, vol. 24, no. 4, pp. 351–358, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. J. M. Peterson and D. C. Guttridge, “Skeletal muscle diseases, inflammation, and NF-κB signaling: insights and opportunities for therapeutic intervention,” International Reviews of Immunology, vol. 27, no. 5, pp. 375–387, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Sandri, “Signaling in muscle atrophy and hypertrophy,” Physiology, vol. 23, no. 3, pp. 160–170, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. N. Zanou and P. Gailly, “Skeletal muscle hypertrophy and regeneration: Interplay between the myogenic regulatory factors (MRFs) and insulin-like growth factors (IGFs) pathways,” Cellular and Molecular Life Sciences, vol. 70, no. 21, pp. 4117–4130, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. G. O. Hopkins, J. McDougall, K. R. Mills, D. A. Isenberg, and A. Ebringer, “Muscle changes in ankylosing spondylitis,” British Journal of Rheumatology, vol. 22, no. 3, pp. 151–157, 1983. View at Google Scholar
  8. J. G. Tidball, “Inflammatory processes in muscle injury and repair,” American Journal of Physiology—Regulatory Integrative and Comparative Physiology, vol. 288, no. 2, pp. R345–R353, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. W. E. Mitch and A. L. Goldberg, “Mechanisms of disease: mechanisms of muscle wasting: the role of the ubiquitin-proteasome pathway,” The New England Journal of Medicine, vol. 335, no. 25, pp. 1897–1905, 1996. View at Publisher · View at Google Scholar · View at Scopus
  10. N. Sahin, E. Ozcan, A. Baskent, A. Karan, O. Ekmeci, and E. Kasikcioglu, “Isokinetic evaluation of ankle muscle strength and fatigue in patients with ankylosing spondylitis,” European Journal of Physical and Rehabilitation Medicine, vol. 47, no. 3, pp. 399–405, 2011. View at Google Scholar · View at Scopus
  11. N. Sahin, E. Ozcan, A. Baskent, A. Karan, and E. Kasikcioglu, “Muscular kinetics and fatigue evaluation of knee using by isokinetic dynamometer in patients with ankylosing spondylitis,” Acta Reumatologica Portuguesa, vol. 36, no. 3, pp. 252–259, 2011. View at Google Scholar · View at Scopus
  12. S. Marcora, F. Casanova, E. Williams, J. Jones, R. Elamanchi, and A. Lemmey, “Preliminary evidence for cachexia in patients with well-established ankylosing spondylitis,” Rheumatology, vol. 45, no. 11, pp. 1385–1388, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. V. Matschke, J. G. Jones, A. B. Lemmey, P. J. Maddison, and J. M. Thom, “Patellar tendon properties and lower limb function in rheumatoid arthritis and ankylosing spondylitis versus healthy controls: A Cross-Sectional Study,” The Scientific World Journal, vol. 2013, Article ID 514743, 8 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. I. Sari, T. Demir, L. D. Kozaci et al., “Body composition, insulin, and leptin levels in patients with ankylosing spondylitis,” Clinical Rheumatology, vol. 26, no. 9, pp. 1427–1432, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. E. J. Giltay, D. van Schaardenburg, L. J. G. Gooren, P. J. Kostense, and B. A. C. Dijkmans, “Decreased serum biochemical markers of muscle origin in patients with ankylosing spondylitis,” Annals of the Rheumatic Diseases, vol. 58, no. 9, pp. 541–545, 1999. View at Publisher · View at Google Scholar · View at Scopus
  16. E. Toussirot, F. Michel, and D. Wendling, “Bone density, ultrasound measurements and body composition in early ankylosing spondylitis,” Rheumatology, vol. 40, no. 8, pp. 882–888, 2001. View at Publisher · View at Google Scholar · View at Scopus
  17. É. Toussirot, G. Streit, N. U. Nguyen et al., “Adipose tissue, serum adipokines, and ghrelin in patients with ankylosing spondylitis,” Metabolism: Clinical and Experimental, vol. 56, no. 10, pp. 1383–1389, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. F. P. Dos Santos, A. Constantin, M. Laroche et al., “Whole body and regional bone mineral density in ankylosing spondylitis,” Journal of Rheumatology, vol. 28, no. 3, pp. 547–549, 2001. View at Google Scholar · View at Scopus
  19. G. Plasqui, A. Boonen, P. Geusens, E. J. Kroot, M. Starmans, and S. van der Linden, “Physical activity and body composition in patients with ankylosing spondylitis,” Arthritis Care & Research, vol. 64, no. 1, pp. 101–107, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. S. Faus-Riera, S. Martinez-Pardo, J. Blanch-Rubio, P. Benito-Ruiz, J. C. Duro-Pujol, and J. M. Corominas-Torres, “Muscle pathology in ankylosing spondylitis: clinical, enzymatic, electromyographic and histologic correlation,” Journal of Rheumatology, vol. 18, no. 9, pp. 1368–1371, 1991. View at Google Scholar · View at Scopus
  21. M. Carrabba, M. Chevallard, B. Colombo, F. Dworzak, M. Mora, and F. Cornelio, “Muscle pathology in ankylosing spondylitis,” Clinical and Experimental Rheumatology, vol. 2, no. 2, pp. 139–144, 1984. View at Google Scholar · View at Scopus
  22. M. Rudwaleit, D. van der Heijde, R. Landewé et al., “The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection,” Annals of the Rheumatic Diseases, vol. 68, no. 6, pp. 777–783, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. S. Garrett, T. Jenkinson, L. G. Kennedy, H. Whitelock, P. Gaisford, and A. Calin, “A new approach to defining disease status in ankylosing spondylitis: the bath ankylosing spondylitis disease activity index,” The Journal of Rheumatology, vol. 21, no. 12, pp. 2286–2291, 1994. View at Google Scholar · View at Scopus
  24. A. Calin, S. Garrett, H. Whitelock, J. O'Hea, P. Mallorie, and T. Jenkinson, “A new approach to defining functional ability in ankylosing spondylitis: the development of the bath ankylosing spondylitis functional index,” Journal of Rheumatology, vol. 21, no. 12, pp. 2281–2285, 1994. View at Google Scholar · View at Scopus
  25. S. D. Jones, J. Porter, S. L. Garrett, L. G. Kennedy, H. Whitelock, and A. Calin, “A new scoring system for the Bath Ankylosing Spondylitis Metrology Index (BASMI),” Journal of Rheumatology, vol. 22, no. 8, p. 1609, 1995. View at Google Scholar · View at Scopus
  26. R. N. Baumgartner, K. M. Koehler, D. Gallagher et al., “Epidemiology of sarcopenia among the elderly in New Mexico,” American Journal of Epidemiology, vol. 147, no. 8, pp. 755–763, 1998. View at Publisher · View at Google Scholar · View at Scopus
  27. A. Nana, G. J. Slater, W. G. Hopkins, and L. M. Burke, “Effects of daily activities on dual-energy X-ray absorptiometry measurements of body composition in active people,” Medicine and Science in Sports and Exercise, vol. 44, no. 1, pp. 180–189, 2012. View at Publisher · View at Google Scholar · View at Scopus
  28. A. Nana, G. J. Slater, W. G. Hopkins, and L. M. Burke, “Effects of exercise sessions on DXA measurements of body composition in active people,” Medicine and Science in Sports and Exercise, vol. 45, no. 1, pp. 178–185, 2013. View at Publisher · View at Google Scholar · View at Scopus
  29. A. J. Murton and P. L. Greenhaff, “Resistance exercise and the mechanisms of muscle mass regulation in humans: acute effects on muscle protein turnover and the gaps in our understanding of chronic resistance exercise training adaptation,” International Journal of Biochemistry and Cell Biology, vol. 45, no. 10, pp. 2209–2214, 2013. View at Publisher · View at Google Scholar · View at Scopus
  30. A. L. Mackey, M. Kjaer, N. Charifi et al., “Assessment of satellite cell number and activity status in human skeletal muscle biopsies,” Muscle and Nerve, vol. 40, no. 3, pp. 455–465, 2009. View at Publisher · View at Google Scholar · View at Scopus
  31. J. C. Bruusgaard, I. B. Johansen, I. M. Egner, Z. A. Rana, and K. Gundersen, “Myonuclei acquired by overload exercise precede hypertrophy and are not lost on detraining,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 34, pp. 15111–15116, 2010. View at Publisher · View at Google Scholar · View at Scopus
  32. E. Rigamonti, P. Zordan, C. Sciorati, P. Rovere-Querini, and S. Brunelli, “Macrophage plasticity in skeletal muscle repair,” BioMed Research International, vol. 2014, Article ID 560629, 9 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  33. T. R. Ackland, T. G. Lohman, J. Sundgot-Borgen et al., “Current status of body composition assessment in sport: review and position statement on behalf of the Ad Hoc research working group on body composition health and performance, under the auspices of the I.O.C. medical commission,” Sports Medicine, vol. 42, no. 3, pp. 227–249, 2012. View at Publisher · View at Google Scholar · View at Scopus
  34. A. J. Blazevich, D. R. Coleman, S. Horne, and D. Cannavan, “Anatomical predictors of maximum isometric and concentric knee extensor moment,” European Journal of Applied Physiology, vol. 105, no. 6, pp. 869–878, 2009. View at Publisher · View at Google Scholar · View at Scopus
  35. J. L. Andersen and P. Aagaard, “Effects of strength training on muscle fiber types and size; consequences for athletes training for high-intensity sport,” Scandinavian Journal of Medicine and Science in Sports, vol. 20, no. 2, pp. 32–38, 2010. View at Publisher · View at Google Scholar · View at Scopus
  36. P. Aagaard, E. B. Simonsen, J. L. Andersen, P. Magnusson, and P. Dyhre-Poulsen, “Increased rate of force development and neural drive of human skeletal muscle following resistance training,” Journal of Applied Physiology, vol. 93, no. 4, pp. 1318–1326, 2002. View at Publisher · View at Google Scholar · View at Scopus
  37. G. Prebeg, I. Cuk, D. Suzovic, S. Stojiljkovic, D. Mitic, and S. Jaric, “Relationships among the muscle strength properties as assessed through various tests and variables,” Journal of Electromyography and Kinesiology, vol. 23, no. 2, pp. 455–461, 2013. View at Publisher · View at Google Scholar · View at Scopus
  38. J. P. Folland and A. G. Williams, “The adaptations to strength training: morphological and neurological contributions to increased strength,” Sports Medicine, vol. 37, no. 2, pp. 145–168, 2007. View at Publisher · View at Google Scholar · View at Scopus
  39. R. H. Fitts and J. J. Widrick, “Muscle mechanics: adaptations with exercise-training,” Exercise and Sport Sciences Reviews, vol. 24, pp. 427–473, 1996. View at Google Scholar · View at Scopus
  40. J. K. Petrella, J.-S. Kim, J. M. Cross, D. J. Kosek, and M. M. Bamman, “Efficacy of myonuclear addition may explain differential myofiber growth among resistance-trained young and older men and women,” American Journal of Physiology—Endocrinology and Metabolism, vol. 291, no. 5, pp. E937–E946, 2006. View at Publisher · View at Google Scholar · View at Scopus
  41. J. C. Bruusgaard, I. M. Egner, T. K. Larsen, S. Dupre-Aucouturier, D. Desplanches, and K. Gundersen, “No change in myonuclear number during muscle unloading and reloading,” Journal of Applied Physiology, vol. 113, no. 2, pp. 290–296, 2012. View at Publisher · View at Google Scholar · View at Scopus
  42. J. K. Petrella, J.-S. Kim, D. L. Mayhew, J. M. Cross, and M. M. Bamman, “Potent myofiber hypertrophy during resistance training in humans is associated with satellite cell-mediated myonuclear addition: a cluster analysis,” Journal of Applied Physiology, vol. 104, no. 6, pp. 1736–1742, 2008. View at Publisher · View at Google Scholar · View at Scopus
  43. K. E. Hanssen, N. H. Kvamme, T. S. Nilsen et al., “The effect of strength training volume on satellite cells, myogenic regulatory factors, and growth factors,” Scandinavian Journal of Medicine and Science in Sports, vol. 23, no. 6, pp. 728–739, 2013. View at Publisher · View at Google Scholar · View at Scopus
  44. T. Snijders, L. B. Verdijk, J. S. J. Smeets et al., “The skeletal muscle satellite cell response to a single bout of resistance-type exercise is delayed with aging in men,” Age, vol. 36, no. 4, article 9699, 2014. View at Publisher · View at Google Scholar · View at Scopus
  45. M. Saclier, S. Cuvellier, M. Magnan, R. Mounier, and B. Chazaud, “Monocyte/macrophage interactions with myogenic precursor cells during skeletal muscle regeneration,” The FEBS Journal, vol. 280, no. 17, pp. 4118–4130, 2013. View at Publisher · View at Google Scholar · View at Scopus
  46. D. J. Freidenreich and J. S. Volek, “Immune responses to resistance exercise,” Exercise Immunology Review, vol. 18, pp. 8–41, 2012. View at Google Scholar · View at Scopus
  47. S. Halvorsen, N. K. Vøllestad, C. Fongen et al., “Physical fitness in patients with ankylosing spondylitis: comparison with population Controls,” Physical Therapy, vol. 92, no. 2, pp. 298–309, 2012. View at Publisher · View at Google Scholar · View at Scopus
  48. B. J. Schoenfeld, “The use of nonsteroidal anti-inflammatory drugs for exercise-induced muscle damage: implications for skeletal muscle development,” Sports Medicine, vol. 42, no. 12, pp. 1017–1028, 2012. View at Publisher · View at Google Scholar · View at Scopus
  49. Q. A. Soltow, J. L. Betters, J. E. Sellman, V. A. Lira, J. H. D. Long, and D. S. Criswell, “Ibuprofen inhibits skeletal muscle hypertrophy in rats,” Medicine and Science in Sports and Exercise, vol. 38, no. 5, pp. 840–846, 2006. View at Publisher · View at Google Scholar · View at Scopus
  50. M. L. Novak, W. Billich, S. M. Smith et al., “COX-2 inhibitor reduces skeletal muscle hypertrophy in mice,” American Journal of Physiology—Regulatory Integrative and Comparative Physiology, vol. 296, no. 4, pp. R1132–R1139, 2009. View at Publisher · View at Google Scholar · View at Scopus
  51. S. Schiaffino, K. A. Dyar, S. Ciciliot, B. Blaauw, and M. Sandri, “Mechanisms regulating skeletal muscle growth and atrophy,” The FEBS Journal, vol. 280, no. 17, pp. 4294–4314, 2013. View at Publisher · View at Google Scholar · View at Scopus
  52. K. Briot, P. Garnero, A. Le Henanff, M. Dougados, and C. Roux, “Body weight, body composition, and bone turnover changes in patients with spondyloarthropathy receiving anti-tumour necrosis factor α treatment,” Annals of the Rheumatic Diseases, vol. 64, no. 8, pp. 1137–1140, 2005. View at Publisher · View at Google Scholar · View at Scopus
  53. K. Briot, L. Gossec, S. Kolta, M. Dougados, and C. Roux, “Prospective assessment of body weight, body composition, and bone density changes in patients with spondyloarthropathy receiving anti-tumor necrosis factor-α treatment,” Journal of Rheumatology, vol. 35, no. 5, pp. 855–861, 2008. View at Google Scholar · View at Scopus
  54. I. Hmamouchi, C. Roux, S. Paternotte, S. Kolta, M. Dougados, and K. Briot, “Early increase of abdominal adiposity in patients with spondyloarthritis receiving anti-tumor necrosis factor-α treatment,” Journal of Rheumatology, vol. 41, no. 6, pp. 1112–1117, 2014. View at Publisher · View at Google Scholar · View at Scopus
  55. L. D. Renzo, R. Saraceno, C. Schipani et al., “Prospective assessment of body weight and body composition changes in patients with psoriasis receiving anti-TNF-α treatment,” Dermatologic Therapy, vol. 24, no. 4, pp. 446–451, 2011. View at Publisher · View at Google Scholar · View at Scopus
  56. S. M. Marcora, K. R. Chester, G. Mittal, A. B. Lemmey, and P. J. Maddison, “Randomized phase 2 trial of anti-tumor necrosis factor therapy for cachexia in patients with early rheumatoid arthritis,” American Journal of Clinical Nutrition, vol. 84, no. 6, pp. 1463–1472, 2006. View at Google Scholar · View at Scopus
  57. G. S. Metsios, A. Stavropoulos-Kalinoglou, K. M. J. Douglas et al., “Blockade of tumour necrosis factor-α in rheumatoid arthritis: effects on components of rheumatoid cachexia,” Rheumatology, vol. 46, no. 12, pp. 1824–1827, 2007. View at Publisher · View at Google Scholar · View at Scopus
  58. H. Nemoto, S. Konno, H. Sugimoto et al., “Anti-TNF therapy using etanercept suppresses degenerative and inflammatory changes in skeletal muscle of older SJL/J mice,” Experimental and Molecular Pathology, vol. 90, no. 3, pp. 264–270, 2011. View at Publisher · View at Google Scholar · View at Scopus
  59. N. V. Ermolova, L. Martinez, S. A. Vetrone et al., “Long-term administration of the TNF blocking drug Remicade (cV1q) to mdx mice reduces skeletal and cardiac muscle fibrosis, but negatively impacts cardiac function,” Neuromuscular Disorders, vol. 24, no. 7, pp. 583–595, 2014. View at Publisher · View at Google Scholar · View at Scopus
  60. I. Toft, S. Lindal, K. H. Bønaa, and T. Jenssen, “Quantitative measurement of muscle fiber composition in a normal population,” Muscle and Nerve, vol. 28, no. 1, pp. 101–108, 2003. View at Publisher · View at Google Scholar · View at Scopus
  61. A. Eriksson, F. Kadi, C. Malm, and L.-E. Thornell, “Skeletal muscle morphology in power-lifters with and without anabolic steroids,” Histochemistry and Cell Biology, vol. 124, no. 2, pp. 167–175, 2005. View at Publisher · View at Google Scholar · View at Scopus